EyeNet - American Academy of Ophthalmology

Shop

Advertisement
EyeNet Magazine /

Latest Issue

May 2013

Diabetic Retinal Disease: Keeping Up With Evolving Therapies

Anti-VEGF drugs, laser, steroids, and even systemic therapies—more options are available than ever before. How your patients can benefit.

Ophthalmic Pearls

Performing an Endoscopic Conjunctivodacryocystorhinostomy

By J. Javier Servat, MD, Flora Levin, MD, Francesca D. Nesi-Eloff, MD, and Frank A. Nesi, MD, FACS
Edited by Ingrid U. Scott, MD, MPH, and Sharon Fekrat, MD

Indications, benefits, and step-by-step procedure using a frosted Pyrex tube for this endoscopic procedure.

Comments 0

Views 137

Clinical Update

Glued IOL Technique Gaining Support

By Linda Roach, Contributing Writer
Interviewing Amar Agarwal, MBBS, FRCOphth, Lisa B. Arbisser, MD, Robert A. Eden, MD, and Michael E. Snyder, MD

For most cataract surgeons, the process of securing an IOL in an eye with weak zonules or a torn capsule means either implanting an anterior chamber IOL or suturing a posterior chamber IOL into the ciliary sulcus. But interest in a newer way to secure IOLs in these problem eyes is on the rise.

Comments 0

Views 1239

New Research Sheds Light on Intermittent Exotropia

By Marianne Doran, Contributing Writer
Interviewing Michael P. Clarke, FRCOphth, Sean P. Donahue, MD, PhD, and K. David Epley, MD

Intermittent exotropia: new research on treatment and outcomes.

Comments 0

Views 1295

Anti-VEGF Treatment and Dry AMD: Finding the Balance

By Miriam Karmel, Contributing Writer
Interviewing Martin Friedlander, MD, PhD, Daniel F. Martin, MD, and Philip J. Rosenfeld, MD, PhD

Is anti-VEGF therapy linked with geographic atrophy and dry AMD?

Comments 0

Views 467

Morning Rounds

A Splitting Dilemma

By Yasha S. Modi, MD, Catherine Cukras, MD, PhD, Philip J. Rosenfeld, MD, PhD, and Audina M. Berrocal, MD
Edited by Steven J. Gedde, MD

This 5-year-old experienced painless loss of vision and the appearance of dark shadows—first in his left eye, then in his right. What’s your diagnosis?

Comments 0

Views 1031

Blink

Solar Eclipse Maculopathy

By Robin A. Vora, MD, The Permanente Medical Group, Oakland, Calif., and Poorab K. Sangani, MD, The Permanente Medical Group, Daly City, Calif., and edited by Michael P. Kelly, FOPS
Photographed by Maryann Fajardo, The Permanente Medical Group, Daly City, Calif.

A 36-year-old man noticed spots in the central vision of both eyes five days after watching a partial solar eclipse.

Comments 0

Views 104

Journal Highlights

A Review of the Literature

Ophthalmology: Use of SD-OCT to identify glaucoma progression. ■ AJO: Intravitreal bevacizumab for retinal arterial macroaneurysm. ■ JAMA Ophthalmology: Macular thinning and X-linked Alport syndrome. And more.

Comments 0

Views 1

News in Review

Commentary and Perspectives

Retina: New statin-AMD finding surprises researchers. ■ Pediatrics: Algorithm may help identify infants with severe ROP. ■ Refractive Cataract: Functional cost for some multifocal IOL users ■ Anti-VEGF Therapy: Injection-IOP connection.

Comments 0

Views 1

Academy Notebook

News, Tips, Resources

What’s Happening: New AAOE website. ■ EyeWiki resident contest winners. ■ Ask the ethicist: FDA warning letters. ■ D.C. Report: potential cuts to come. And more.

Comments 0

Views 191

Practice Perfect

6 Tips for the After-Hours Telephone Consult

By Jean Shaw, Contributing Writer
Interviewing Andrew Doan, MD, PhD, Anne M. Menke, RN, PhD, and Ronald W. Pelton, MD, PhD

OMIC experts describe how you should drive the conversation, document it, and give your patients guidelines on when to call you back.

Comments 0

Views 68

Savvy Coder

Coding Is Not for Amateurs Anymore

By Sue Vicchrilli, COT, OCS, Academy Coding Executive

Use the Ophthalmic Coding Specialist exam to ensure coding competency at your practice. Test yourself with six sample questions.

Comments 0

Views 82

Opinion

Hospital Diversification and Alice’s Restaurant?

Richard P. Mills, MD, MPH, Chief Medical Editor, on health care regulation.

Comments 0

Views 2

Current Perspective

Love and Money

David W. Parke II, MD, Executive Vice President/CEO, on the trend of Integration in health care delivery.

Comments 0

Views 4

Letters

Thoughts From Your Colleagues

Off-label use of devices. ■ Ophthalmic drug costs.

Comments 0

Views 2

Diabetic Retinal Disease: Keeping Up With Evolving Therapies

Ophthalmic Pearls

Clinical Update

Morning Rounds

Blink

Journal Highlights

News in Review

Academy Notebook

Practice Perfect

Savvy Coder

Opinion

Current Perspective

Letters

OUR SITES

FOLLOW THE ACADEMY